Skip to main content
Top
Published in: Abdominal Radiology 12/2020

01-12-2020 | Prostate Cancer | Special Section: Prostate cancer update

Round table: arguments against using multiparametric prostate MRI protocols

Authors: Ryan Ward, Andrei S. Purysko

Published in: Abdominal Radiology | Issue 12/2020

Login to get access

Abstract

Biparametric MRI (bpMRI), which uses only T2-weighted imaging and diffusion-weighted imaging, continues to gain support for the detection of prostate cancer, as this imaging technique offers many benefits over traditional mpMRI. However, the Prostate Imaging Reporting and Data System (PI-RADS) v2.1 document released in 2019 emphasized that mpMRI is still preferred over bpMRI in most clinical scenarios. As one article in a series of four providing arguments for and against using mpMRI and bpMRI protocols, this paper provides arguments against using mpMRI. Within this article, we discuss recent data suggesting equivalent performance between bpMRI and mpMRI in the detection of prostate cancer. The limited utility of dynamic contrast enhancement in the evaluation of prostate cancer according to the PI-RADS v2.1 document is also reviewed. Finally, we detail the large financial and time costs, legal and logistical issues, and potential for patient harm that must be considered with the administration of contrast.
Literature
1.
go back to reference Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, et al. Update of the AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer. J Urol [Internet]. 2019;101097JU0000000000000617. Available from: http://dx.doi.org/10.1097/JU.0000000000000617 Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, et al. Update of the AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer. J Urol [Internet]. 2019;101097JU0000000000000617. Available from: http://​dx.​doi.​org/​10.​1097/​JU.​0000000000000617​
2.
go back to reference Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MGM. Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis. Eur Urol [Internet]. 2015 [cited 2019 Sep 2];68:438–50. Available from: http://www.sciencedirect.com/science/article/pii/S0302283814012202 Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MGM. Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis. Eur Urol [Internet]. 2015 [cited 2019 Sep 2];68:438–50. Available from: http://​www.​sciencedirect.​com/​science/​article/​pii/​S030228381401220​2
4.
go back to reference Niu X-K, Chen X-H, Chen Z-F, Chen L, Li J, Peng T. Diagnostic Performance of Biparametric MRI for Detection of Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol [Internet]. Am Roentgen Ray Soc; 2018;211:369–78. Available from: http://dx.doi.org/10.2214/AJR.17.18946 Niu X-K, Chen X-H, Chen Z-F, Chen L, Li J, Peng T. Diagnostic Performance of Biparametric MRI for Detection of Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol [Internet]. Am Roentgen Ray Soc; 2018;211:369–78. Available from: http://​dx.​doi.​org/​10.​2214/​AJR.​17.​18946
5.
go back to reference Woo S, Suh CH, Kim SY, Cho JY, Kim SH, Moon MH. Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol [Internet]. 2018;211:W226–41. Available from: http://dx.doi.org/10.2214/AJR.18.19880 Woo S, Suh CH, Kim SY, Cho JY, Kim SH, Moon MH. Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol [Internet]. 2018;211:W226–41. Available from: http://​dx.​doi.​org/​10.​2214/​AJR.​18.​19880
7.
go back to reference Kang Z, Min X, Weinreb J, Li Q, Feng Z, Wang L. Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol [Internet]. 2019;212:357–65. Available from: http://dx.doi.org/10.2214/AJR.18.20103 Kang Z, Min X, Weinreb J, Li Q, Feng Z, Wang L. Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol [Internet]. 2019;212:357–65. Available from: http://​dx.​doi.​org/​10.​2214/​AJR.​18.​20103
8.
go back to reference De Visschere P, Lumen N, Ost P, Decaestecker K, Pattyn E, Villeirs G. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Clin Radiol [Internet]. 2017;72:23–32. Available from: http://dx.doi.org/10.1016/j.crad.2016.09.011 De Visschere P, Lumen N, Ost P, Decaestecker K, Pattyn E, Villeirs G. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Clin Radiol [Internet]. 2017;72:23–32. Available from: http://​dx.​doi.​org/​10.​1016/​j.​crad.​2016.​09.​011
9.
go back to reference Vargas HA, Hötker AM, Goldman DA, Moskowitz CS, Gondo T, Matsumoto K, et al. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol [Internet]. 2016;26:1606–12. Available from: http://dx.doi.org/10.1007/s00330-015-4015-6 Vargas HA, Hötker AM, Goldman DA, Moskowitz CS, Gondo T, Matsumoto K, et al. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol [Internet]. 2016;26:1606–12. Available from: http://​dx.​doi.​org/​10.​1007/​s00330-015-4015-6
11.
go back to reference Junker D, Steinkohl F, Fritz V, Bektic J, Tokas T, Aigner F, et al. Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations? World J Urol [Internet]. 2019;37:691–9. Available from: http://dx.doi.org/10.1007/s00345-018-2428-y Junker D, Steinkohl F, Fritz V, Bektic J, Tokas T, Aigner F, et al. Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations? World J Urol [Internet]. 2019;37:691–9. Available from: http://​dx.​doi.​org/​10.​1007/​s00345-018-2428-y
13.
go back to reference Barnett CL, Davenport MS, Montgomery JS, Wei JT, Montie JE, Denton BT. Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer. BJU Int [Internet]. 2018;122:50–8. Available from: http://dx.doi.org/10.1111/bju.14151 Barnett CL, Davenport MS, Montgomery JS, Wei JT, Montie JE, Denton BT. Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer. BJU Int [Internet]. 2018;122:50–8. Available from: http://​dx.​doi.​org/​10.​1111/​bju.​14151
15.
go back to reference Lotan Y, Haddad AQ, Costa DN, Pedrosa I, Rofsky NM, Roehrborn CG. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy. Urol Oncol [Internet]. 2015;33:266.e9–16. Available from: http://dx.doi.org/10.1016/j.urolonc.2015.03.007 Lotan Y, Haddad AQ, Costa DN, Pedrosa I, Rofsky NM, Roehrborn CG. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy. Urol Oncol [Internet]. 2015;33:266.e9–16. Available from: http://​dx.​doi.​org/​10.​1016/​j.​urolonc.​2015.​03.​007
16.
go back to reference Venderink W, Govers TM, de Rooij M, Fütterer JJ, Sedelaar JPM. Cost-Effectiveness Comparison of Imaging-Guided Prostate Biopsy Techniques: Systematic Transrectal Ultrasound, Direct In-Bore MRI, and Image Fusion. AJR Am J Roentgenol [Internet]. 2017;208:1058–63. Available from: http://dx.doi.org/10.2214/AJR.16.17322 Venderink W, Govers TM, de Rooij M, Fütterer JJ, Sedelaar JPM. Cost-Effectiveness Comparison of Imaging-Guided Prostate Biopsy Techniques: Systematic Transrectal Ultrasound, Direct In-Bore MRI, and Image Fusion. AJR Am J Roentgenol [Internet]. 2017;208:1058–63. Available from: http://​dx.​doi.​org/​10.​2214/​AJR.​16.​17322
17.
go back to reference Gordon LG, James R, Tuffaha HW, Lowe A, Yaxley J. Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia. J Magn Reson Imaging [Internet]. 2017;45:1304–15. Available from: http://dx.doi.org/10.1002/jmri.25504 Gordon LG, James R, Tuffaha HW, Lowe A, Yaxley J. Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia. J Magn Reson Imaging [Internet]. 2017;45:1304–15. Available from: http://​dx.​doi.​org/​10.​1002/​jmri.​25504
19.
go back to reference de Rooij M, Crienen S, Witjes JA, Barentsz JO, Rovers MM, Grutters JPC. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol [Internet]. 2014;66:430–6. Available from: http://dx.doi.org/10.1016/j.eururo.2013.12.012 de Rooij M, Crienen S, Witjes JA, Barentsz JO, Rovers MM, Grutters JPC. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol [Internet]. 2014;66:430–6. Available from: http://​dx.​doi.​org/​10.​1016/​j.​eururo.​2013.​12.​012
21.
go back to reference van der Leest M, Israël B, Cornel EB, Zámecnik P, Schoots IG, van der Lelij H, et al. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility. Eur Urol [Internet]. 2019;76:574–81. Available from: http://dx.doi.org/10.1016/j.eururo.2019.05.029 van der Leest M, Israël B, Cornel EB, Zámecnik P, Schoots IG, van der Lelij H, et al. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility. Eur Urol [Internet]. 2019;76:574–81. Available from: http://​dx.​doi.​org/​10.​1016/​j.​eururo.​2019.​05.​029
23.
go back to reference Lorusso A, Quaia E, Poillucci G, Stacul F, Grisi G, Cova MA. Activity-based cost analysis of contrast-enhanced ultrasonography (CEUS) related to the diagnostic impact in focal liver lesion characterisation. Insights Imaging [Internet]. 2015;6:499–508. Available from: http://dx.doi.org/10.1007/s13244-015-0402-4 Lorusso A, Quaia E, Poillucci G, Stacul F, Grisi G, Cova MA. Activity-based cost analysis of contrast-enhanced ultrasonography (CEUS) related to the diagnostic impact in focal liver lesion characterisation. Insights Imaging [Internet]. 2015;6:499–508. Available from: http://​dx.​doi.​org/​10.​1007/​s13244-015-0402-4
24.
go back to reference Choi MH, Kim CK, Lee YJ, Jung SE. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study. AJR Am J Roentgenol [Internet]. Am Roentgen Ray Soc; 2019;212:839–46. Available from: http://dx.doi.org/10.2214/AJR.18.20498 Choi MH, Kim CK, Lee YJ, Jung SE. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study. AJR Am J Roentgenol [Internet]. Am Roentgen Ray Soc; 2019;212:839–46. Available from: http://​dx.​doi.​org/​10.​2214/​AJR.​18.​20498
26.
go back to reference Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol [Internet]. 2007;189:1533–8. Available from: http://dx.doi.org/10.2214/AJR.07.2554 Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol [Internet]. 2007;189:1533–8. Available from: http://​dx.​doi.​org/​10.​2214/​AJR.​07.​2554
31.
go back to reference Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, et al. Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists. Can J Kidney Health Dis [Internet]. 2018;5:2054358118778573. Available from: http://dx.doi.org/10.1177/2054358118778573 Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, et al. Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists. Can J Kidney Health Dis [Internet]. 2018;5:2054358118778573. Available from: http://​dx.​doi.​org/​10.​1177/​2054358118778573​
35.
37.
go back to reference Agency EM. EMA’s final opinion confirms restrictions on use of linear gadolinium agents in body scans. European Medicines Agency London; 2017. Agency EM. EMA’s final opinion confirms restrictions on use of linear gadolinium agents in body scans. European Medicines Agency London; 2017.
39.
Metadata
Title
Round table: arguments against using multiparametric prostate MRI protocols
Authors
Ryan Ward
Andrei S. Purysko
Publication date
01-12-2020
Publisher
Springer US
Published in
Abdominal Radiology / Issue 12/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02456-z

Other articles of this Issue 12/2020

Abdominal Radiology 12/2020 Go to the issue

Special Section: Prostate cancer update

Perspective: a critical assessment of PI-RADS 2.1